Trial Profile
A Study to Evaluate the Abuse Potential of Oral Eluxadoline versus Oxycodone in Healthy Recreational Opioid Users
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 22 Apr 2016
Price :
$35
*
At a glance
- Drugs Eluxadoline (Primary)
- Indications Irritable bowel syndrome
- Focus Adverse reactions
- 22 Apr 2016 New trial record
- 12 Mar 2016 Results presented at the 117th Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics